Enforcement record

Cease and Desist Order disclosure naming ロート製薬株式会社

ロート製薬株式会社 (Act against Unjustifiable Premiums and Misleading Representations)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

Act against Unjustifiable Premiums and Misleading RepresentationsConsumer Affairs AgencyGovernment disclosure25 March 2025

Action type

Cease and Desist Order

Law

Act against Unjustifiable Premiums and Misleading Representations

Authority

Consumer Affairs Agency

Action date

25 March 2025

RegBase evidence report

Japanese public-record enforcement check

Saveable record of the published action, regulator source, source status, and review notes for internal compliance files.

Report ID: RB-EN-ENFORCEMENT-KEIHYOHO-ROTOZHI--202608041528
Generated at: 5 August 2026 at 00:28
Record URL: https://regbase.jp/en/enforcement/keihyoho-rotozhi-yao-20250325

1. Review Summary

Disclosure name	ロート製薬株式会社	Corporate Number	Not stated in the disclosure
Enforcement record	1 record	Other confirmed records for this company	Outside this report's scope
Action date	25 March 2025	Authority	Consumer Affairs Agency
Law	Act against Unjustifiable Premiums and Misleading Representations	Action type	Cease and Desist Order
Source status	Preserved public-source archive recorded

This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.

2. Published Information

Published name	ロート製薬株式会社

3. Enforcement Record

Target name in disclosure	ロート製薬株式会社
Authority	Consumer Affairs Agency (消費者庁)
Law / action type	Act against Unjustifiable Premiums and Misleading Representations / Cease and Desist Order
Action / announcement date	Action: 25 March 2025 / Announcement: 7 March 2026
English summary	Regarding the display related to the supplement called 'Rohto V5 Act Vision a' supplied by the company, acts violating the Act against Unjustifiable Premiums and Misleading Representations (corresponding to Article 5, Paragraph 3 of the Act, Stealth Marketing Notice) were recognized.
Original Japanese text	同社が供給する「ロートV5アクトビジョンa」と称するサプリメントに係る表示について、景品表示法に違反する行為(同法第5条第3号(ステルスマーケティング告示)に該当)
Official source	https://www.caa.go.jp/notice/entry/041488/
Source archive	https://kiroku.today/a/cf1e472b88hcv2z8
Extraction / evidence timestamps	Extracted: 25 April 2026 at 08:14 / Evidence checked: 25 April 2026 at 08:14 / Archive captured: 12 July 2026 at 14:35

4. Business Location and Permit Details

No additional structured business-location or permit fields are recorded for this disclosure.

5. Other Confirmed Records for This Company

This report covers the single government disclosure shown on this page.

Reviewer Notes

Reviewer		Team / company
Review purpose
Additional notes

□ Official source URL or archived source was checked.
□ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
□ This document is understood as a public-record evidence file, not a credit decision or legal opinion.

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Free report

Save the disclosure record naming ロート製薬株式会社

Includes the published name, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.

Preserved evidence by Kiroku

Review the preserved source for ロート製薬株式会社

Open the preserved public source with its capture time, original artifact, available verification data, and downloadable evidence pack.

Open preserved source and evidence pack

For developers: JSON integration details

You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.

/api/v1/enforcements?company=%E3%83%AD%E3%83%BC%E3%83%88%E8%A3%BD%E8%96%AC%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE&limit=10

Open JSON Specs

Action summary

Company: ロート製薬株式会社Japanese only
Original: ロート製薬株式会社
Governing law: Act against Unjustifiable Premiums and Misleading Representations
景品表示法
Action type: Cease and Desist Order
措置命令
Action date: 25 March 2025
Issuing authority: Consumer Affairs Agency
消費者庁
Industry context: 医薬品・サプリメント

Violation

Machine-translated summary — verify against original

Regarding the display related to the supplement called 'Rohto V5 Act Vision a' supplied by the company, acts violating the Act against Unjustifiable Premiums and Misleading Representations (corresponding to Article 5, Paragraph 3 of the Act, Stealth Marketing Notice) were recognized.

Show original Japanese text

同社が供給する「ロートV5アクトビジョンa」と称するサプリメントに係る表示について、景品表示法に違反する行為(同法第5条第3号(ステルスマーケティング告示)に該当)

Compliance context

Medium-high

A formal administrative corrective order requiring remedial measures under the cited law.

Consumer protection and advertising law covering misleading representations and unjustifiable premiums.

Check the official source for the exact conduct, corrective obligations, and whether similar marketing or sales practices continue.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Evidence pack

Original Consumer Affairs Agency source (Japanese)Open preserved source and evidence pack

Extracted at: 2026-04-24T23:14:21.325+00:00
Evidence checked: 2026-04-24T23:14:21.325+00:00
Archive captured: 2026-07-12T05:35:24.982661+00:00

Show audit JSON

{
  "record": {
    "id": "febf8e07-7680-4721-92bb-e135cf028c94",
    "url": "https://regbase.jp/en/enforcement/keihyoho-rotozhi-yao-20250325",
    "company_name_original": "ロート製薬株式会社",
    "company_name_registry": null,
    "corporate_number": null,
    "law": {
      "ja": "景品表示法",
      "en": "Act against Unjustifiable Premiums and Misleading Representations"
    },
    "action_type": {
      "ja": "措置命令",
      "en": "Cease and Desist Order"
    },
    "authority": {
      "ja": "消費者庁",
      "en": "Consumer Affairs Agency"
    }
  },
  "entity_match": {
    "status": "unresolved",
    "confidence": 85,
    "method": "nta_strict_name_nationally_unique",
    "method_label": "nta_strict_name_nationally_unique",
    "notes": "NTA full-download lookup found a nationally unique exact registered-name candidate (ロート製薬株式会社). No Corporate Number was present in the disclosure, so this remains a likely match."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "Medium-high",
    "actionMeaning": "A formal administrative corrective order requiring remedial measures under the cited law.",
    "practicalNote": "Check the official source for the exact conduct, corrective obligations, and whether similar marketing or sales practices continue.",
    "lawContext": "Consumer protection and advertising law covering misleading representations and unjustifiable premiums."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/keihyoho-rotozhi-yao-20250325",
    "officialSourceUrl": "https://www.caa.go.jp/notice/entry/041488/",
    "officialDocumentUrl": null,
    "archiveUrl": "https://kiroku.today/a/cf1e472b88hcv2z8",
    "archivedSourceUrl": "https://www.caa.go.jp/notice/entry/041488/",
    "archiveCapturedAt": "2026-07-12T05:35:24.982661+00:00",
    "extractedAt": "2026-04-24T23:14:21.325+00:00",
    "translatedAt": "2026-05-01T06:40:15.183+00:00",
    "evidenceCheckedAt": "2026-04-24T23:14:21.325+00:00",
    "generatedAt": "2026-08-04T15:28:52.535Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

Language

日本語版を見る (Japanese)

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.